Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 506 entries
View as:

Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03074318 Org: User:
Start: 09/28/17 End: 11/15/20 Due: 11/15/21

Effects of Garlic Supplements on Opioids in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00499460 Org: User:
Start: 11/30/06 End: 08/31/08 Due: 08/31/09

Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00012207 Org: User:
Start: 09/30/00 End: 07/31/10 Due: 07/31/11

Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT00217386 Org: User:
Start: 03/31/04 End: - Due: -

Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00003196 Org: User:
Start: 09/30/97 End: 04/30/02 Due: 04/30/03

Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01377168 Org: User:
Start: 05/31/14 End: 06/30/17 Due: 06/30/18

Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01769911 Org: User:
Start: 02/28/15 End: - Due: -

Glucosamine and Chondroitin in Preventing Inflammation in Overweight Patients

Phase: N/A Priority: Normal
NCT ID: NCT03827161 Org: User:
Start: 08/01/17 End: 12/01/18 Due: 12/01/19

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00723099 Org: User:
Start: 06/25/08 End: 07/31/18 Due: 07/31/19

Improving Smoking Cessation Quitlines: Pilot Study of Acceptance Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01525420 Org: User:
Start: 03/31/12 End: 03/31/13 Due: 03/31/14

Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00002792 Org: User:
Start: 06/30/96 End: 04/30/03 Due: 04/30/04

Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00014235 Org: User:
Start: 12/31/00 End: - Due: -

Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00003081 Org: User:
Start: 03/31/98 End: 01/31/02 Due: 01/31/03

Molecular Profile of Breast Cancer in Ugandan Patients With Stage IIB-III Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03518242 Org: User:
Start: 06/06/18 End: 05/04/22 Due: 05/04/23

Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

Phase: N/A Priority: Normal
NCT ID: NCT01929408 Org: User:
Start: 07/19/13 End: 12/04/18 Due: 12/04/19

Telephone-Delivered Interventions for Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT02421991 Org: User:
Start: 11/02/15 End: 12/31/19 Due: 12/31/20

Early Discharge and Outpatient Care After Chemotherapy in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00844441 Org: User:
Start: 12/31/08 End: 03/31/11 Due: 03/31/12

Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01477021 Org: User:
Start: 01/31/12 End: - Due: -

Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02943668 Org: User:
Start: 03/02/17 End: 12/17/18 Due: 12/17/19

Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003899 Org: User:
Start: 01/31/99 End: 11/30/01 Due: 11/30/02

Adaptive Treatment Strategies for Improving Engagement With a Web-Based Smoking Intervention in Socially Anxious Smokers

Phase: N/A Priority: Normal
NCT ID: NCT04260776 Org: User:
Start: 04/15/22 End: 12/31/24 Due: 12/31/25

Therapeutic Autologous Lymphocytes, Aldesleukin, and Denileukin Diftitox in Treating Patients With Stage III-IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00945269 Org: User:
Start: 07/31/09 End: 01/31/11 Due: 01/31/12

Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm

Phase: N/A Priority: Normal
NCT ID: NCT03531918 Org: User:
Start: 09/14/18 End: 11/01/21 Due: 11/01/22

BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03502577 Org: User:
Start: 05/23/18 End: 04/20/22 Due: 04/20/23

Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01235572 Org: User:
Start: 12/31/10 End: 07/31/14 Due: 07/31/15